NCT05039749

Brief Summary

Human centric lighting (HCL) is a technology that supports the body's circadian rhythm, as it can stimulate the sleep triggering hormone, melatonin, to improve sleep hygiene over standard lighting (SL), and promote recuperative sleep for a timely return-to-duty. In intensive care units, exposure to HCL has improved sleep measures. However, the effect in the medical surgical (MS) environment is unknown. The purpose of this study is to assess the feasibility of study procedures in MS setting and conduct a preliminary evaluation of the effect of light on inpatient sleep. Recruitment started November 2020 through April 2021. Data analysis is pending.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 25, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 10, 2021

Completed
Last Updated

September 10, 2021

Status Verified

September 1, 2021

Enrollment Period

6 months

First QC Date

June 25, 2021

Last Update Submit

September 3, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • Total Sleep Time

    Assess the feasibility of measuring total sleep time in MS setting, using an actigraphy device.

    During participant's inpatient stay, not to exceed 5 days.

  • Sleep Efficiency

    Assess the feasibility of measuring sleep efficiency in MS setting, using an actigraphy device.

    During participant's inpatient stay, not to exceed 5 days.

  • Sleep Patterns

    Assess the feasibility of assessing sleep patterns in MS setting, using a Consensus Sleep Diary (CSD).

    During participant's inpatient stay, not to exceed 5 days.

  • Dim Light Melatonin Onset - collection

    Assess the feasibility of collecting samples to assess dim light melatonin onset in MS setting, using passive drool saliva sampling.

    During participant's inpatient stay, not to exceed 5 days.

  • Patient experience

    Describe the patient's experience of participating in the study, in a MS setting, using a semi-structured interview (SSI).

    One time - approximately a 5 to 15 minute interview

Secondary Outcomes (1)

  • Dim Light Melatonin Onset - analysis

    Collected during participant's inpatient stay, not to exceed 5 days.

Study Arms (2)

Human Central Lighting (HCL) Room

EXPERIMENTAL

This inpatient room was outfitted with lights that mimic the day/night cycle, thereby supporting circadian rhythm. Day time lights were automatically on during 0600 to 1900 and in use any time the patients would normally utilize their lights, with a goal of three hours of light exposure per day. The lights automatically transitioned to warmer toned evening lighting at 1900.

Device: Human Centric Lights

Standard Hospital Lighting (SL) Room

NO INTERVENTION

The lighting in this room was standard florescent hospital lighting. The only changes in the lighting was the on/off settings normally associated with lighting.

Interventions

Bright light is emitted during the day from 06:00, then auto-dimmed light is used at night, beginning 19:00.

Human Central Lighting (HCL) Room

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient who is an active duty service member, GS Civilian, Dependent or Retiree affiliated with the Army, Air Force or Navy.
  • Patient who is informed by provider or anticipates being admitted for at least two nights.
  • Patient who can read and speak English fluently (since surveys are not translated in any other language).

You may not qualify if:

  • Patient with visual impairment which cannot be corrected with glasses or contact lenses such as complete blindness, (defined as inability to see light), or partial blindness (defined as very limited vision) such as patients with history of cataracts.
  • Patient taking an oral medication for sleep.
  • Patient receiving radioactive ionization treatment.
  • Patient who requires isolation or palliative care.
  • Patient recovering from head/neck or oral maxillofacial surgery that would impede saliva sample collection (i.e. jaw wiring, extensive gauze packing in oral cavity)
  • Patient who reports status as a Department of Defense Contractor at screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Landstuhl Regional Medical Center

Landstuhl, Germany

Location

MeSH Terms

Conditions

Parasomnias

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Pauline A Swiger, PhD

    US Army Landstuhl Regional Medical Ceneter

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
On-Site Principal Investigator

Study Record Dates

First Submitted

June 25, 2021

First Posted

September 10, 2021

Study Start

November 1, 2020

Primary Completion

April 30, 2021

Study Completion

May 15, 2021

Last Updated

September 10, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations